The antidepressant debate

descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Mar 2002 English Publisher:Royal College of PsychiatristsJournal:British Journal of Psychiatry, volume 180, pages 193-194 (issn: 0007-1250, eissn: 1472-1465,

Copyright policy )

Authors: Joanna, Moncrieff;

doi: 10.1192/bjp.180.3.193

pmid: 11872507

The antidepressant debate

- Summary
- Subjects
- Metrics

Abstract

There has been an extensive debate recently in the North American medical literature and general press concerning the efficacy of antidepressant drugs. Little of this has reached the European press. Andrews' editorial ([Andrews, 2001][1]) is a welcome contribution but focuses only on the reasons for

Related Organizations

University College London
United Kingdom

Keywords

Clinical Trials as Topic, Depressive Disorder, Bias, Humans, Placebo Effect, Antidepressive Agents

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	41
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%